MYELODYSPLASIA
Clinical trials for MYELODYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radical transplant trial aims to replace diseased blood systems
Disease control Recruiting nowThis study is testing a specific type of stem cell transplant using donated umbilical cord blood to treat patients with serious blood cancers and disorders. The procedure involves high-dose chemotherapy and radiation to wipe out the patient's diseased bone marrow before infusing …
Matched conditions: MYELODYSPLASIA
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Three-Drug shield tested to protect cancer patients after transplant
Disease control Recruiting nowThis study is testing a combination of three medications given after a stem cell transplant to prevent a dangerous complication called graft-versus-host disease (GVHD). It will enroll 124 adults with leukemia or similar blood cancers who are receiving a transplant from a donor. T…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Hannah Choe, MD • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New test could pinpoint cause of mysterious low platelet disorder
Diagnosis Recruiting nowThis study is testing whether a specific lab test that looks for antibodies against a person's own platelets can help doctors diagnose immune thrombocytopenia (ITP) faster and more accurately. It will enroll 225 adults who have been found to have low platelet counts. The goal is …
Matched conditions: MYELODYSPLASIA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Mar 23, 2026 15:19 UTC